ICH Q3C Impurities: Guideline for Residual Solvents

E1538245 UNEXPLORED

ICH Q3C Impurities: Guideline for Residual Solvents is an international harmonization guideline that sets health-based limits and control strategies for residual organic solvents in pharmaceuticals to ensure product safety and quality.

Try in SPARQL Jump to: Surface forms Disambiguation Referenced by

All labels observed (1)

Label	Occurrences
ICH Q3C Impurities: Guideline for Residual Solvents canonical	1

How this entity was disambiguated

This entity first appeared as the object of triple T22456999 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.

NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07

Target entity: ICH Q3C Impurities: Guideline for Residual Solvents
Context triple: [ICH Q3A Impurities in New Drug Substances, relatedGuideline, ICH Q3C Impurities: Guideline for Residual Solvents]

A. ICH Q3B Impurities in New Drug Products
ICH Q3B Impurities in New Drug Products is an ICH quality guideline that sets thresholds and requirements for identifying, reporting, and qualifying impurities present in finished pharmaceutical products.
B. ICH Q3A Impurities in New Drug Substances
ICH Q3A Impurities in New Drug Substances is an international regulatory guideline that sets quality standards and thresholds for identifying, reporting, and controlling impurities in new active pharmaceutical ingredients.
C. ICH Q11 Development and Manufacture of Drug Substances
ICH Q11 Development and Manufacture of Drug Substances is an ICH guideline that provides principles and expectations for the development and manufacturing of chemical and biotechnological drug substances within a quality-by-design framework.
D. ICH Q1 Stability Testing of New Drug Substances and Products
ICH Q1 Stability Testing of New Drug Substances and Products is an international regulatory guideline that defines the scientific principles and study requirements for assessing the stability, shelf life, and storage conditions of new pharmaceutical substances and finished products.
E. ICH Q8 Pharmaceutical Development
ICH Q8 Pharmaceutical Development is an international guideline that outlines a systematic, science- and risk-based approach to pharmaceutical product and process development, forming a core part of the ICH quality framework.
F. None of above. chosen
G. Unsure - the case is ambiguous/there is not enough information to decide.

NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07

Target entity: ICH Q3C Impurities: Guideline for Residual Solvents
Target entity description: ICH Q3C Impurities: Guideline for Residual Solvents is an international harmonization guideline that sets health-based limits and control strategies for residual organic solvents in pharmaceuticals to ensure product safety and quality.

A. ICH Q3B Impurities in New Drug Products
ICH Q3B Impurities in New Drug Products is an ICH quality guideline that sets thresholds and requirements for identifying, reporting, and qualifying impurities present in finished pharmaceutical products.
B. ICH Q3A Impurities in New Drug Substances
ICH Q3A Impurities in New Drug Substances is an international regulatory guideline that sets quality standards and thresholds for identifying, reporting, and controlling impurities in new active pharmaceutical ingredients.
C. ICH Q11 Development and Manufacture of Drug Substances
ICH Q11 Development and Manufacture of Drug Substances is an ICH guideline that provides principles and expectations for the development and manufacturing of chemical and biotechnological drug substances within a quality-by-design framework.
D. ICH Q1 Stability Testing of New Drug Substances and Products
ICH Q1 Stability Testing of New Drug Substances and Products is an international regulatory guideline that defines the scientific principles and study requirements for assessing the stability, shelf life, and storage conditions of new pharmaceutical substances and finished products.
E. ICH Q8 Pharmaceutical Development
ICH Q8 Pharmaceutical Development is an international guideline that outlines a systematic, science- and risk-based approach to pharmaceutical product and process development, forming a core part of the ICH quality framework.
F. None of above. chosen

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

ICH Q3A Impurities in New Drug Substances → relatedGuideline → ICH Q3C Impurities: Guideline for Residual Solvents ⓘ

All labels observed (1)

How this entity was disambiguated Show

Referenced by (1)

How this entity was disambiguated